FindTrial
Sign In

The physiological and pathological role of metabolic sensor protein in obesity and other major diseases

The physiological and pathological role of metabolic sensor protein in obesity and other major diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-COC-17011355
Enrollment
Unknown
Registered
2017-05-11
Start date
2017-06-01
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolism diseases

Interventions

Case series:None

Sponsors

Department of Endocrinology and Metabolism, Shanghai Sixth Peoplel's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. diagnosis of primary obese patients, body mass index BMI =30kg/m2, with a history of weight loss or obesity-related complications; 2. with weight loss will; 3. identified for metabolic surgery.

Exclusion criteria

Exclusion criteria: 1. liver and kidney dysfunction (alanine aminotransferase or aspartate aminotransferase or direct bilirubin higher than the normal upper limit of 1.5 times, or serum creatinine> 115umol/L); 2. ascites, pregnancy status, nausea, cachexia, cachexia; 3. mental illness; 4. greater risk of surgery.

Design outcomes

Primary

MeasureTime frame
molecular mechanism of metabolic surgery in the treatment of obesity and type 2 diabetes mellitus;—

Countries

China

Contacts

Public ContactYuqian Bao

Department of Endocrinology and Metabolism, Shanghai Sixth Peoplel's Hospital

byq522@163.com+86 13788971763

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026